|
ENTA | Enanta Pharmaceuticals Inc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.22 |
| Leverage | 76.95% |
| Market Cap | $ 299.1m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -81.7m |
| Margin | -121.99% |
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company is headquartered in Watertown, Massachusetts.